Cambium Bio Limited has released a press release.
Progenza OA Kyocera negotiations update
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cambium Bio
- Kyocera completes Progenza Due Diligence
- Appendix 4C Updated
- Regeneus to be granted new key Progenza patent in U.S.
- Regeneus receives A$1.6M milestone payment from Kyocera
- Regeneus signs MOU with Kyocera Corporation
Later from Cambium Bio
- Regeneus and Kyocera sign Progenza OA deal
- US Patent for Sygenus
- Regeneus to present at FNN Virtual Investor Event
- Appendix 4E and Annual Report
- Regeneus receives milestone payment from Kyocera
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio